Our main goal is to develop new technologies allowing genomic medicine discoveries.

We are addressing the challenge of disease risk stratification using sequence and phenotypic data in the EHR and leveraging this information to improve the health of patients across diverse patient populations.

Ultimately we hope to deliver discoveries and results to patients and providers for improved diagnosis, medication selection, and risk factor modification.